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Abstract
Objective To describe the implementation of a
formal single-operator led endoscopic mucosal
resection (EMR) service in a district general
hospital, and the effect on patient outcome of
this service development.
Design Prospective audit during initiation and
subsequent development of EMR service.
Setting District general hospital.
Patients All patients referred to EMR service
between 1 January 2008 and 31 December
2011.
Interventions Nil in addition to clinical care.
Main outcomes measured The number of
EMRs per year including polyp size and histology,
recurrence of polyp tissue at 3 months following
EMR, and complications including early/delayed
bleeding and perforation.
Results Following service implementation, the
number of EMRs rose from 11 in 2008 to 35 in
2011, with the number of large polyps (>30 mm)
rising from four in 2008 to 24 in 2011. Recurrent
or residual adenomatous tissue fell from 75% in
2008 to 4.76% in 2011. Only one perforation
occurred over the 4 years (0.8% perforation rate:
1 in 120 polypectomies). A reduction in surgical
intervention for adenomatous polyp removal was
observed during the audit period.
Conclusions Professional engagement and
support by medical, surgical and nursing
members of the endoscopy team promoted
development of skill and confidence in EMR.
Exposure to higher volumes of EMR procedures
allowed successful removal of larger lesions,
while maintained patient safety and reduced the
need for surgical removal of benign polyps.
Introduction
Endoscopic management of benign colorec-
tal polyps continues to develop. Polyps that
were previously referred for surgical resec-
tion are now commonly removed endoscop-
ically. Many centres have endoscopists that
can remove large or flat polyps, but few
have a formal endoscopic mucosal resection
(EMR) service receiving most or all referrals.
In 2007, as an initiative to optimise patient
outcome from endoscopic removal of
benign colonic polyps, the colorectal sur-
geons and gastroenterologists at the Queen
Elizabeth Hospital, Gateshead, agreed that
one endoscopist would specialise in these
procedures. It was decided that large flat or
sessile lesions identified by the medical and
surgical endoscopic team would be referred
for assessment and removal. The following
article is a detailed description of how this
service was instituted and subsequently
developed over the next 4 years. Training
and assessment of the endoscopist, the
involvement of the multidisciplinary team
(MDT), and changes to patient outcomes
over time are discussed. The relevance of
this service development to other district
general hospitals, the wider question of
who should be offering this type of
service, and suggestions for appropriate
quality indicators are considered.
Background
Injection-assisted EMR, often termed
‘‘saline-assisted’’ polypectomy, was first
established in 1973 for flexible colonos-
copy,1 and is now commonly used for
large non-pedunculated colorectal polyps.
The size, anatomical location and accessi-
bility of a polyp relative to mucosal folds
and flexures, determines the technical dif-
ficulty and risk of perforation and bleed-
ing during removal.2–6 Adequate training,
teamwork and quality assurance may lead
to safe and high quality EMR.
Five levels of competency to remove
colorectal polyps have been proposed.7
These vary from level 0 where no lesions
are removed, and all referred to more
272 Frontline Gastroenterology 2012;3:272–277. doi:10.1136/flgastro-2012-100212
ENDOSCOPY
 group.bmj.com on August 7, 2013 - Published by fg.bmj.comDownloaded from 
skilled endoscopists, to level 4 where large flat lesions
or other challenging polyps that may otherwise need
removal surgically, are excised endoscopically. In the
North-East of England there are several endoscopists
with level 4 competency, but to date there is no
formal tertiary referral service, therefore resulting in a
shortfall of clinical provision in hospitals without a
level 4 endoscopist.
Setting up the EMR service
Training and assessment
Ideally endoscopists learning EMR should go through a
formal training period composed of observation and
assisting procedures, prior to performing the technique
under direct observation, and finally independent prac-
tice. There is no formal programme such as this avail-
able in the UK. Mentorship is the training method that
was used in Gateshead. An accredited Bowel Cancer
Screening Programme (BCSP) colonoscopist from a
nearby Institution, with level 4 polypectomy compe-
tency acted as mentor, and provided specific support,
hands on guidance and assessment throughout the early
period of training. This approach facilitated develop-
ment of new skill within Gateshead, avoiding the need
to refer patients to other hospitals for polypectomy.
Level 3 and 4 polypectomies were done jointly, and for-
mative assessments for specific polypectomy procedures
were undertaken.
New procedure committee and business case proposal
EMR polypectomy was formally approved by the hos-
pital New Procedure Committee. A business case was
presented to the endoscopy managers for fortnightly
therapeutic lists of two EMRs per list. Business man-
agers and the Institution were therefore aware of the
development of the service from the outset, specific-
ally the need to reduce patient numbers on these lists
to allow adequate time for the procedure, and the
risks and benefits of the procedure.
Quality assurance and MDT feedback
Continual prospective audit of patient outcomes was
undertaken, with annual presentation to the lower
gastrointestinal (GI) MDT. The endoscopist provided
a regular presence at the lower GI MDT, from where
many of the new referrals came.
Polyp referrals
On referral receipt following discussion at the MDT
or following referral from an endoscopist, a letter was
dictated to patients explaining the EMR procedure,
the risks involved, specifically the risk of perforation,
and the alternative options including surgery. The
letter was copied to the endoscopy unit and an appro-
priate duration of time allocated on an endoscopy list.
The letter was also routinely copied to the referring
endoscopist, and the consent process presented and
discussed annually at the colorectal MDT. The need
for timely referral to the EMR service from diagnostic
endoscopy or CT scan was reinforced to prevent
undue delay in consent letters being sent to patients.
The procedures outlined in this manuscript were
those performed between 1 January 2008 and 31
December 2011 after referral by a medical or surgical
endoscopist as part of the new EMR service. Lesions
are also reported that were identified by the EMR
endoscopist on a routine diagnostic list, and subse-
quently brought back for an EMR procedure after
appropriate consent.
Outcomes of the EMR service
Referrals
Table 1 outlines the patients undergoing EMR from
service establishment through the next 4 years. There
was an approximate four-fold increase seen in patients
receiving this procedure as part of the EMR service.
Some patients had more than one polyp requiring
EMR. The mean time from sending a consent
letter to patients, and performing the index EMR pro-
cedure remained similar across all year groups at
between 4–5 weeks.
Polyp size
During the early stages of the EMR service, the majority
of polyps were small, over 50% less than 20 mm, and
only a third over 30 mm. As the service developed the
proportion of larger polyps increased, such that by
2011 almost 85% of polyps were over 20 mm, of which
more than two thirds were over 30 mm in size.
Figure 1 demonstrates the absolute numbers of polyps
removed per year according to polyp size, revealing a
clear year on year increase in the number of larger
polyps removed, particularly those 30 mm or more.
Histology
From 2009 onwards, there was a clear increase in
polyps confirmed as either adenomatous or malignant
after removal. Overall this histology accounted for
between approximately 90% and 96% of polyp diag-
noses. Polyps not identified as adenomatous or malig-
nant were found to be inflammatory, hyperplastic or
metaplastic.
Both the cancers identified in 2008 and 2009 showed
invasion up to the resection margins. However, the four
cancers removed by EMR in 2010 and 2011 were com-
pletely cleared with no evidence of local invasion,
lymphadenopathy or metastasis on colonic resection or
subsequent imaging. None of the attempted or removed
polyps were known to be cancers prior to EMR, all
were thought to be adenomatous.
Recurrence
In the EMR service, recurrence is assessed endoscop-
ically at 3 months following index EMR in those
patients identified as having adenomas. Photos are
routinely taken of the polypectomy scar to prove
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clearance. If any residual islands of adenoma are seen,
these are biopsied, and either raised and snared if pos-
sible, or destroyed with Argon Plasma Coagulation.
Reasons for not performing EMR at 3 months include
the finding of non-adenomatous histology or malig-
nancy at index EMR, intercurrent co-morbidity
making EMR higher risk, or patient preference not to
undergo a repeat procedure.
As demonstrated in table 1, in 2008, the adenoma
recurrence at 3 months was 75% (n=6/8), however this
subsequently fell to 46.7% (n=7/15) in 2009, 22.22%
(n=8/36) in 2010, and 4.76% (n=1/21) in 2011.
Statistics for 2010 and 2011 are therefore comparable
with other published series, which describe a recurrence
rate of between 1.7–28% at follow up examination.8–12
Complications
The hospital Patient Administration System was inter-
rogated to identify the 30-day re-admission rate
following EMR, and notes were reviewed to establish
the cause of re-admission. Complications were charac-
terised as immediate peri-procedural bleeding that
required therapy (eg, endoclips or adrenaline),
delayed bleeding leading to re-admission, post-
polypectomy syndrome leading to re-admission, per-
foration, and death. A summary of complications is
presented in table 2.
In 2008 there was one immediate bleed following a
25 mm polyp removal, controlled with adrenaline
injection and endoclips. The patient was admitted for
3 days observation then discharged. The day following
discharge the patient experienced a cardiac arrest and
died. Post mortem examination identified a perfor-
ation at the polypectomy site. A root cause analysis
investigation performed concluded that the death was
related to the polypectomy, with a delayed
perforation.
In 2009 there was one delayed bleed 7 days follow-
ing removal of a 40 mm rectal polyp. This required
Figure 1 Number of endoscopic mucosal resections
performed per year, stratified according to polyp size.
Table 2 Summary of annual endoscopic mucosal resection
complications
2008
(n=11)
2009
(n=26)
2010
(n=48)
2011
(n=35)
Post polypectomy
syndrome requiring
re-admission: n (%)
– – 1 (2.08) –
Immediate bleed: n (%) 1 (9.09) – 2 (4.17) –
Delayed bleed requiring
re-admission: n (%)
– 1 (3.85) 3 (6.25) 1 (2.86)
Perforation: n (%) 1 (9.09) – – –
Death: n (%) 1 (9.09) – – –
Table 1 Polyp size, histology and 3 month recurrence for patients undergoing endoscopic mucosal resection (EMR) between 2008 and
2011
2008 2009 2010 2011
Patients undergoing EMR (n) 11 23 48 33
EMRs performed (n)* 11 26 48 35
Mean time from consent letter to index EMR in days (range) 34.25 (15–48) 30.29 (4–56) 31.57 (4–80) 35.58 (2–169)
Relative size of polyps
<20 mm (%) 54.55 50 35.42 17.14
20–29 mm (%) 9.09 11.54 27.08 25.71
≥30 mm (%) 36.36 38.46 37.5 57.14
Range of polyp size (mm) 8–80 10–80 4–120 10–60
Ultimate histology
Adenoma: n (%) 8/11 (72.73) 24/26 (92.31) 40/48 (83.33) 32/35 (91.43)
Malignancy: n (%) 1/11 (9.09) 1/26 (3.85) 3/48 (6.25) 1/35 (2.86)
Hyperplastic/metaplastic/inflammatory: n (%) 2/11 (18.18) 1/26 (3.85) 5/48 (10.42) 2/35 (5.71)
Polyp recurrence at 3 month endoscopy: n (%)
Overall 6/8 (75.00) 7/15 (46.7) 8/36 (22.22) 1/21 (4.76)
<20 mm (n) 2 2 1
20–29 mm (n) 1 3
≥30 mm (n) 4 4 4 1
*A small number of patients had more than one polyp requiring EMR.
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re-admission and was managed successfully with
adrenaline, injection and endoclips.
In 2010 there were two peri-procedural bleeds after
a 20 mm and 40 mm polypectomy respectively, both
responded to endoscopic therapy without further
need for intervention. Both were admitted overnight
for observation. One received adrenaline and endo-
clips, the other adrenaline and heater probe therapy.
There were three delayed bleeds, two of which were
in patients with polyps greater than 30 mm. One
patient was admitted, re-endoscoped and treated suc-
cessfully with adrenaline and heater probe therapy.
The other two patients were admitted for observation,
but no intervention was necessary. One patient was
admitted the same day as the EMR with severe
abdominal pain and peritonism. A CT scan showed no
evidence of perforation, they were commenced on
intravenous antibiotics and the pain settled. The
patient was discharged 48 h later with a presumed
diagnosis of post polypectomy syndrome.
There was only one complication in 2011. This was
a delayed bleed, requiring a two unit blood transfu-
sion but no endoscopic therapy.
Overall bleeding rates requiring admission are com-
parable with published series, which describe a risk of
between 2.9% and 16%.5 8–11 13
The overall perforation rate for the 4 years was
0.8% (1 in 120 polypectomies).
Polyps not attempted or not completed
In addition to the EMRs outlined in table 1, each
year, there were a small number of patients in which
the procedure was either not attempted or not
completed.
There were three cases overall where after consider-
ation of the risks and benefits of the procedure, the
patients decided not to proceed to EMR (two in
2010, one in 2011). In all cases the patient also
declined surgery.
In three cases the endoscopist decided not to
attempt EMR (two in 2010, one in 2011). In two of
these, therapeutic endoscopy was not attempted due
to an adverse risk:benefit ratio as a consequence of
significant co-morbidity (advanced liver disease and
dementia respectively). The other procedure was not
attempted, as at endoscopy the lesion was complex
and extensively involved the caecum and ileo-caecal
valve. The patient in this circumstance was referred
on for surgery.
Over the 4 years there were a total of nine incom-
plete polypectomies, where the endoscopist was tech-
nically unable to clear all the polyp tissue at EMR
(two in each of 2008–2010, three in 2011). Five were
due to non-lifting of the polyp on injection, preclud-
ing successful snare, and in the remaining four
patients complete removal was unsuccessful after pro-
longed de-bulking. In total six of these nine polyps
were found to be malignant. Five were primary
colonic cancers, and one a metastatic deposit from an
ovarian primary.
Reduction in surgical resection rates
An audit of surgery for benign colonic lesions ana-
lysed all resection specimens in 2005 and 2010. Six
resections for adenomatous colorectal lesions were
performed in 2005. None had attempted EMR and
lesions varied from one that would have been technic-
ally challenging (a carpet like lesion in the caecum,
80×65 mm measured at resection) and five lesions
that would now be routinely attempted endoscopically
(25 mm sessile caecal, 45 mm sessile rectal, 65 mm
pedunculated sigmoid, 20 mm sessile rectal, 20 mm
sessile caecal polyps respectively). In 2010 there were
three resections for adenomatous colorectal lesions.
One was technically challenging covering the caecum
and ileocaecal valve and referred for surgery (after
EMR assessment) as described above. One was not
referred to the EMR service (60 mm pedunculated
ascending) and the other was assessed as not remov-
able by one of the other gastroenterologists as it did
not rise with injection.
Discussion
The six gastroenterologists at Gateshead work collab-
oratively. All undertake ‘core’ gastroenterology provi-
sion including upper and lower GI endoscopic
therapy; however, all also have areas of specialist inter-
est. The team was supportive of one endoscopist
setting up a service to provide EMR, enabling one
operator to gain the experience of increasing numbers
of larger polyps. Subsequently the other gastroenterol-
ogists no longer routinely undertake EMR of large
polyps. The data presented in this manuscript demon-
strates that over a 4-year period as the new service
became established in the Organisation, the number
of procedures performed by this service increased
fourfold and was associated with a reduction in recur-
rent/residual adenomatous tissue from 75% in the 1st
year, to 4.76% in the 4th year. This was coupled with
an overall reduction in the incidence of serious com-
plications including perforation, immediate and
delayed bleeding. Resection rates for benign disease
have fallen since service introduction, and the surgical
approach to removal of benign lesions has undoubt-
edly changed during this time, with EMR now the
preferred first option. Consequently, this suggests a
significant improvement in patient outcome as a result
of the service development. This also suggests that
increased therapeutic experience, initially of approxi-
mately 50 procedures and higher annual procedure
volumes of at least 30 procedures, leads to better
patient outcome.
Based on the Gateshead experience, box 1 outlines
suggestions for setting up a formalised EMR service in
a district general hospital. Crucial to implementation
of this type of service is training and ongoing support
Frontline Gastroenterology 2012;3:272–277. doi:10.1136/flgastro-2012-100212 275
ENDOSCOPY
 group.bmj.com on August 7, 2013 - Published by fg.bmj.comDownloaded from 
from a more experienced endoscopist. Assessment,
feedback and reflection is as useful in learning more
advanced techniques such as EMR polypectomy, as it
is when learning the basics of colonoscopy. The
recently developed and validated Direct Observation
of Polypectomy Skills (DOPyS) proforma may allow
objective assessment of skills development.14
Recurrent or residual adenomatous tissue is more
difficult to remove after a prior attempt at polypect-
omy due to fibrosis, and so clearance at first EMR is
desirable.9 In the Gateshead series, all but one polyp
were cleared by further snare and diathermy on 2nd
or subsequent attempts. The reduction in 3-month
adenoma recurrence seen in Gateshead suggests one
endoscopist performing this procedure in a non-
specialist district general hospital is preferable to
many endoscopists performing EMR; however,
depending on the workload of the hospital and to
ensure cover during periods of annual leave it may be
advisable for two endoscopists to take responsibility
for such a service. Although adenomatous polyp
recurrence is a clear marker of outcome following
EMR, the data presented suggests other quality indi-
cators when establishing an EMR service. These are
described in box 2.
Data from the Gateshead EMR service highlights
that training in EMR takes several years after inde-
pendence in diagnostic colonoscopy. Consequently it
is unlikely that the annual number of cases for the
average district general hospital is large enough to
allow training of registrars, and maintenance of skills
for a dedicated consultant. Development of EMR
skills as part of registrar training may therefore only
be appropriate in large centres, with sufficient training
opportunities to allow clear progression of skills.
Which endoscopists should be providing an EMR
service is unclear. It could be argued that only BCSP
endoscopists should be performing these procedures,
as they now undertake formal assessment of poly-
pectomy technique and large polyps are detected by
the BCSP. However in Gateshead, 95% of colonos-
copies are performed within the symptomatic
routine endoscopy service, and so there is a signifi-
cant chance of identifying polyps requiring EMR in
this population, as outlined in this manuscript. With
appropriate training, and experience, non-BCSP
endoscopists can successfully provide a safe and
effective service. Box 3 outlines some technical tips
learned as a result of the development of the EMR
service at Gateshead.
Conclusions
EMR is the treatment of choice for most large benign
adenomatous polyps in the colon. Endoscopic skill to
remove these larger polyps takes time to develop and
recurrence rate is a good quality indicator of how this
skill improves. Supportive colleagues, a supportive
management structure and above all good trainers
and mentors are essential for a service to develop and
flourish.
Box 3 Technical tips
▸ Book adequate time/avoid over-booking lists especially when starting a
service off—Full clearance at first polypectomy session is desirable.
▸ Maximise access and visualisation with position change/short scope/busco-
pan/washing (suction nearby pools in case of perforation).
▸ Use dye to raise polyps (clarifying margins) and to enhance pit pattern
identification.
▸ Increase ‘bite size’ at your own pace. Avoid worrying about en bloc resection
rate early (almost all recurrence/residual can be managed—perforation can
be fatal).
▸ Start small and take on bigger polyps gradually. Refer more complex polyps
to experienced colleagues and see how they do it.
▸ Snares have their own technical characteristics which take time to master.
Get used to one snare—it can be made to do most things. Small snares are
useful for limited access and a stiff snare for ‘slippery’ flat lesions.
Box 1 Suggestions for setting up an endoscopic
mucosal resection (EMR) service in a district general
hospital
▸ Depending on annual EMR volume, identify one or two endoscopists willing
to develop the necessary skills to introduce and maintain the service. Two
endoscopists may be preferable to facilitate continuous service without inter-
ruption for leave periods, and provides an extra experienced pair of hands
for complex procedures. Alternatively endoscopists from neighbouring
Institutions can pair with one another to provide this type of service across
two or more hospitals.
▸ Gain support from endoscopic colleagues and the lower GI multidisciplinary
team (MDT).
▸ A business case helps to justify EMR lists to endoscopy managers, and
allows enough time for complex procedures.
▸ Prepare the patient, the Institution and yourself for risk of perforation and
bleeding. Perforation should be expected in 1% of EMR polypectomies and
can often be managed endoscopically.
▸ Early procedures should be undertaken with the supervision of an experi-
enced, ideally level four polypectomy competent endoscopist.
▸ At least 30 procedures per year should be performed per endoscopist to
maintain competency.
▸ Regular formal assessment of technique should be undertaken using DOPyS
polypectomy assessment score sheet.
▸ Perform regular audit and present results to the Lower GI MDT annually.
▸ Be flexible and responsive to referrals ensuring timely index EMR and consist-
ent follow up and discharge.
▸ Always attend Lower GI MDT and liaise with other ‘EMR colleagues’ in the
region on complex cases.
Box 2 Considerations for quality indicators when
setting up an endoscopic mucosal resection (EMR)
service
▸ Time to index EMR from consent letter or diagnostic procedure.
▸ Appropriate consent outlining higher risk of complication than standard
colonoscopy, including risk of perforation, bleeding and pain.
▸ Incidence of complications.
▸ Recurrence/residual adenomatous tissue at 3 months.
▸ Continuous or at least 6 monthly audit of service and patient outcomes.
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What is already known on this topic
▸ EMR is an established therapeutic procedure to remove large sessile or flat
adenomatous lesions within the colon.
What this study adds
▸ This study demonstrates that the development of a high quality EMR service
can be achieved in a district general hospital, producing patient outcomes
comparable to published series.
▸ This was achieved by collaborative working between physician, surgeon and
nursing colleagues to support the training of, and subsequent referral to a
designated therapeutic endoscopist whom would specialise in this technique.
How this study might impact on clinical practice in
the foreseeable future
▸ The training model and prospective assessment of outcomes described in this
paper may be employed by other Institutions to deliver similar high quality
EMR services.
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